Northwest Biotherapeutics, Inc. Share Price
Stocks
NWBO
US66737P6007
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
01:29:53 05/06/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.2050 USD | +0.49% |
|
+22.75% | -10.38% |
| Market Cap | 26Cr 23Cr 22Cr 20Cr 37Cr 2.5TCr 37Cr 259.01Cr 100.03Cr 1.27TCr 98Cr 96Cr 4.09TCr | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 36Cr 31Cr 30Cr 27Cr 50Cr 3.42TCr 51Cr 354.69Cr 136.98Cr 1.74TCr 133.73Cr 130.83Cr 5.61TCr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 9.89x |
| Free-Float |
95.22% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.49% | ||
| 1 week | +22.75% | ||
| Current month | +20.46% | ||
| 1 month | +8.12% | ||
| 3 months | +5.72% | ||
| 6 months | +0.04% | ||
| Current year | -10.38% |
| 1 week | 0.15 |  | 0.21 |
| 1 month | 0.15 | | 0.21 |
| Current year | 0.14 | | 0.34 |
| 1 year | 0.14 | | 0.34 |
| 3 years | 0.14 | | 0.94 |
| 5 years | 0.14 | | 2.05 |
| 10 years | 0.14 | | 2.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alton Boynton
CEO | Chief Executive Officer | 82 | 01/06/2007 |
Linda Powers
CEO | Chief Executive Officer | 71 | 08/06/2011 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/01/2000 |
| Director | Title | Age | Since |
|---|---|---|---|
Alton Boynton
BRD | Director/Board Member | 82 | 01/01/1998 |
Linda Powers
CHM | Chairman | 71 | 17/05/2007 |
Navid Malik
BRD | Director/Board Member | 57 | 01/04/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 29/08/24 | Don | Founder | 10,00,000 | 0.0826% | ||
| 09/08/24 | Don | Chief Technology Officer | 30,00,000 | 0.2478% | ||
| 08/08/24 | Don | Founder | 10,00,000 | 0.0826% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.49% | +22.75% | -19.61% | -76.44% | 26Cr | |
| -0.37% | -3.67% | +57.21% | +87.75% | 7.18TCr | |
| +1.23% | -0.05% | +39.89% | +85.63% | 6.01TCr | |
| +0.19% | +1.61% | +35.10% | +17.20% | 2.79TCr | |
| -0.14% | -2.75% | -14.13% | +356.79% | 2.57TCr | |
| +0.57% | +1.10% | +1.02% | -2.89% | 2.49TCr | |
| +0.65% | +1.67% | +26.47% | -7.62% | 2.09TCr | |
| -1.70% | +0.43% | +150.24% | +323.16% | 1.5TCr | |
| +0.36% | +2.01% | +49.51% | +160.70% | 1.45TCr | |
| +3.91% | -3.51% | -4.56% | +517.49% | 1.39TCr | |
| Average | +0.52% | -1.37% | +32.11% | +146.18% | 2.75TCr | |
| Weighted average by Cap. | +0.40% | -1.91% | +38.58% | +128.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 3.89Cr 3.42Cr 3.24Cr 2.94Cr 5.52Cr 373.73Cr 5.55Cr 39Cr 15Cr 190.71Cr 15Cr 14Cr 612.83Cr |
| Net income | - | - |
| Net Debt | 9.61Cr 8.45Cr 7.99Cr 7.25Cr 14Cr 922.28Cr 14Cr 96Cr 37Cr 470.62Cr 36Cr 35Cr 1.51TCr | 12Cr 11Cr 10Cr 9.42Cr 18Cr 1.2TCr 18Cr 124.41Cr 48Cr 611.97Cr 47Cr 46Cr 1.97TCr |
Employees
105
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/26/28 | $0.1525 | -4.69% | 39,18,070 |
| 25/26/25 | $0.1600 | +0.25% | 23,48,226 |
| 24/26/24 | $0.1596 | -0.03% | 23,91,461 |
| 23/26/23 | $0.1597 | -2.06% | 24,43,603 |
| 22/26/22 | $0.1630 | -2.40% | 27,78,235 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1525USD
Average target price
1.000USD
Spread / Average Target
+555.74%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- NWBO Stock
Select your edition
All financial news and data tailored to specific country editions
